|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please
sign in and mark matches as correct or incorrect.
|
| Serra M, Di Maio A, Bassareo V, et al. (2023) Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration. Neurobiology of Disease. 106226 |
| Lopez-Cuina M, Guérin P, Dutheil N, et al. (2023) GRK2-Targeted Knockdown as Therapy for Multiple System Atrophy. Movement Disorders : Official Journal of the Movement Disorder Society |
| Darricau M, Katsinelos T, Raschella F, et al. (2022) Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates. Brain : a Journal of Neurology |
| Teil M, Doudnikoff E, Thiolat ML, et al. (2022) The Zinc Ionophore Clioquinol Reduces Parkinson's Disease Patient-Derived Brain Extracts-Induced Neurodegeneration. Molecular Neurobiology |
| Arotcarena ML, Soria FN, Cunha A, et al. (2022) Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal function. Aging Cell. 21: e13584 |
| Teil M, Dovero S, Bourdenx M, et al. (2022) Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology. Brain : a Journal of Neurology |
| Bezard E, Dehay B. (2022) [Aggregation and spread of synuclein in Parkinson's disease]. Medecine Sciences : M/S. 38: 45-51 |
| Laferrière F, Claverol S, Bezard E, et al. (2022) Similar neuronal imprint and no cross-seeded fibrils in α-synuclein aggregates from MSA and Parkinson's disease. Npj Parkinson's Disease. 8: 10 |
| Novello S, Mercatelli D, Albanese F, et al. (2022) In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. Neurobiology of Disease. 162: 105579 |
| Blesa J, Foffani G, Dehay B, et al. (2021) Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? Nature Reviews. Neuroscience |